Notably, ZEB1 and Twist1 were recently identified as downstream targets of fibroblast growth factor receptor 1 (FGFR1)/forkhead box M1 (FOXM1) in glioblastoma, and their expression is highly associated with resistance to radiotherapy [120]. Here, FOXM1 is linked to glioblastoma.